As an economist, James Glassman absorbs a lot of information, and he has a conversational way of sharing it. Take his view on the "skills gap" between available jobs and candidates' qualifications: ...

The government reported late last year that under a federal subsidy program called 340B, at least 55,000 hospitals, clinics and other “covered entities” paid $66 billion for pharmaceuticals in 2023.

On the C-SPAN Networks: James Glassman is a Senior Economist for the J.P. Morgan Chase with two videos in the C-SPAN Video Library; the first appearance was a 2004 Forum. The year with the highest ...

NEW YORK, April 4 (Reuters) - Wall Street has lowered expectations for the pace of U.S. employment growth following higher than forecast jobless claims last week, but the latest jobs data due Friday ...

James Glassman may shy away from speculating on the short-term performance of the stock market, but he sounds bullish when looking into the future. On Thursday, Glassman, co-author of the best-selling ...

The steady decline in hours worked this year is a sign that businesses are becoming more cautious, James Glassman, an economist formerly with JPMorgan Chase, said in an email. The index for hours ...

Alex Brill and James Glassman in The Wall Street Journal on G-20 membership Brill and Glassman argue that because the membership criteria was so unclear at the founding of the G-20, which meets this ...